TBX2 and breast neoplasm: In this study, we have identified the embryonic transcriptional repressor and anti-senescence factor TBX2 as a novel potent inducer of EMT that directly represses E-cadherin transcription and promotes an aggressive, mesenchymal breast tumor phenotype (Figure 9).